Alnylam Pharmaceuticals (ALNY.MX) Q4 2014 Earnings

5NovConfirmed
Q1 2014
Q2 2014
Q3 2014
Q4 2014
-8.69
-7.48
-6.26
-5.05

Details

Expected EPS
-8.69008
Actual EPS
-7.875385
Surprise EPS
0.81
Surprise Percent
+9.38%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -7.875385 per share for Q4 2014.

0 Comments

Share your thoughts